Literature DB >> 9462666

Full-length complementary DNA of hepatitis C virus genome from an infectious blood sample.

H Aizaki1, Y Aoki, T Harada, K Ishii, T Suzuki, S Nagamori, G Toda, Y Matsuura, T Miyamura.   

Abstract

We constructed a full-length complementary DNA (cDNA) clone of hepatitis C virus (HCV) from a blood sample of an HCV carrier. The blood from the carrier was eventually transfused to a patient who later developed typical posttransfusion hepatitis C. It was also shown to be infectious to chimpanzees. We obtained 12 overlapping cDNA fragments altogether, covering the entire HCV genome. By subcloning and sequencing, clones considered to constitute the major population were selected. We could also detect 98 base pairs of extra sequences at the 3' end of the genome. After confirming the overlapping sequences, we combined the fragments to make a full-length cDNA. The HCV population in the donor was heterogeneous, as determined by their nucleotide sequences of the hypervariable region in envelope protein, but a few virus clones were selected in the recipient after transmission. The similar convergence of the virus population was previously observed when the same blood sample was injected into a chimpanzee. Interestingly, virus clones isolated during the acute phase in the recipient and the chimpanzee had sequences in the hypervariable region identical to that of the full-length cDNA clone. The full-length cDNA clone of HCV constructed in this study may originate from infectious virus clones.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9462666     DOI: 10.1002/hep.510270242

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  24 in total

1.  Genotype- and Subtype-Independent Full-Genome Sequencing Assay for Hepatitis C Virus.

Authors:  Charlotte Hedskog; Krishna Chodavarapu; Karin S Ku; Simin Xu; Ross Martin; Michael D Miller; Hongmei Mo; Evguenia Svarovskaia
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

2.  Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein.

Authors:  Kousuke Nakai; Toru Okamoto; Tomomi Kimura-Someya; Koji Ishii; Chang Kweng Lim; Hideki Tani; Eiko Matsuo; Takayuki Abe; Yoshio Mori; Tetsuro Suzuki; Tatsuo Miyamura; Jack H Nunberg; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

3.  Construction of the Vero cell culture system that can produce infectious HCV particles.

Authors:  Jia Guo; Ran Yan; Guodong Xu; Weiyun Li; Congyi Zheng
Journal:  Mol Biol Rep       Date:  2007-10-25       Impact factor: 2.316

4.  Evaluation of hepatitis C virus core antigen assays in detecting recombinant viral antigens of various genotypes.

Authors:  Mohsan Saeed; Ryosuke Suzuki; Madoka Kondo; Hideki Aizaki; Takanobu Kato; Toshiaki Mizuochi; Takaji Wakita; Haruo Watanabe; Tetsuro Suzuki
Journal:  J Clin Microbiol       Date:  2009-10-07       Impact factor: 5.948

5.  Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector.

Authors:  Heather J Ezelle; Dubravka Markovic; Glen N Barber
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis virus/HCV pseudotype.

Authors:  Roberto Burioni; Yoshiharu Matsuura; Nicasio Mancini; Hideki Tani; Tatsuo Miyamura; Pietro E Varaldo; Massimo Clementi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  Cell fusion activity of hepatitis C virus envelope proteins.

Authors:  S Takikawa; K Ishii; H Aizaki; T Suzuki; H Asakura; Y Matsuura; T Miyamura
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein.

Authors:  Kohji Moriishi; Tamaki Okabayashi; Kousuke Nakai; Kyoji Moriya; Kazuhiko Koike; Shigeo Murata; Tomoki Chiba; Keiji Tanaka; Ryosuke Suzuki; Tetsuro Suzuki; Tatsuo Miyamura; Yoshiharu Matsuura
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein.

Authors:  Hiromichi Hara; Hideki Aizaki; Mami Matsuda; Fumiko Shinkai-Ouchi; Yasushi Inoue; Kyoko Murakami; Ikuo Shoji; Hayato Kawakami; Yoshiharu Matsuura; Michael M C Lai; Tatsuo Miyamura; Takaji Wakita; Tetsuro Suzuki
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

10.  Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection.

Authors:  Hideki Aizaki; Kenichi Morikawa; Masayoshi Fukasawa; Hiromichi Hara; Yasushi Inoue; Hideki Tani; Kyoko Saito; Masahiro Nishijima; Kentaro Hanada; Yoshiharu Matsuura; Michael M C Lai; Tatsuo Miyamura; Takaji Wakita; Tetsuro Suzuki
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.